Provided by Tiger Trade Technology Pte. Ltd.

ZHAOKE OPHTH-B

2.585
+0.0050.19%
Volume:62.00K
Turnover:161.60K
Market Cap:1.42B
PE:-6.77
High:2.630
Open:2.580
Low:2.580
Close:2.580
52wk High:4.280
52wk Low:2.380
Shares:549.00M
HK Float Shares:549.00M
Volume Ratio:0.79
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.382
ROE:-12.02%
ROA:-8.17%
PB:0.77
PE(LYR):-6.77
PS:38.06

Loading ...

Zhaoke Ophthalmology signs exclusive distribution deal with PT Erela for CsA dry eye gel in Indonesia

Reuters
·
Jun 05

Managing Director Li Yeni Increases Holdings in Lee's Pharmaceutical by 41,500 Shares at HK$1.06 Each

Stock News
·
Jun 03

Lee's Pharmaceutical Secures Funding from Gates Foundation for Synthetic Surfactant Project

Stock News
·
Jun 01

Zhaoke Ophthalmology AGM Clears All Resolutions, Renews Share Mandates and Re-appoints KPMG

Bulletin Express
·
May 15

LEE'S PHARM (00950) to Invest RMB 25 Million in Life Sciences Fund, Expanding into Biotech Sector

Stock News
·
May 11

Zhaoke Ophthalmology shifts to fully electronic dissemination of corporate communications

Bulletin Express
·
Apr 23

Zhaoke Ophthalmology Releases Annual Report and Launches Full Electronic Dissemination of Corporate Communications

Bulletin Express
·
Apr 23

Zhaoke Ophthalmology calls 15 May 2026 AGM to seek fresh share mandates, board renewals and Articles overhaul

Bulletin Express
·
Apr 23

Zhaoke Ophthalmology announces annual general meeting notice

Reuters
·
Apr 23

Zhaoke Ophthalmology Limited:2025年业绩与管线进展综述

Bulletin Express
·
Apr 23

Zhaoke Ophthalmology publishes 2025 annual report

Reuters
·
Apr 23

Zhaoke Ophthalmology proposes articles overhaul to allow hybrid meetings, e-voting, treasury shares

Reuters
·
Apr 15

LEE'S PHARM Reports Annual Results with HK$91.94 Million Attributable Profit

Stock News
·
Mar 30

LEE'S PHARM (00950) Receives NMPA Approval for Inrosa

Stock News
·
Mar 25

Zhaoke Ophthalmology-B Reports 2025 Financial Results: Net Loss Narrows 12% to Approximately 209 Million Yuan

Stock News
·
Mar 25

Zhaoke Ophthalmology FY2025 revenue drops 53.86% to RMB 32 million; operating loss narrows 12.32% to RMB 200 million

Reuters
·
Mar 25

Zhaoke Ophthalmology - Aim to Have Total of 12 Commercialized Drugs by End of 2026

THOMSON REUTERS
·
Mar 25

Zhaoke Ophthalmology Ltd - Loss for Year RMB209 Mln

THOMSON REUTERS
·
Mar 25